Skip to main content
Premium Trial:

Request an Annual Quote

Good to Go, On This Ground

The US federal government has cleared the proposed sale of California-based Complete Genomics to China's BGI-Shenzen, The New York Times reports. The acquisition was given the OK by Committee on Foreign Investment in the United States, which examines the national security ramification of sales of US companies to foreign buyers. The Times adds that the Federal Trade Commission still needs to green-light the deal on antitrust grounds.

Some of the security concerns had been raised by Illumina, which placed its own bid for Complete Genomics, as our sister publication GenomeWeb Daily News has reported. "CFIUS reviews of transactions involving state-owned entities have been problematic, and several transactions have been abandoned rather than be subjected to a Presidential order to unwind the transaction," Illumina CEO Jay Flatley wrote in a letter to Complete Genomics in November. Complete Genomics rejected Illumina's bid, saying it did not think the deal would pass antitrust review.

BGI pointed out, however, that Illumina has sold it machines. "Illumina has never previously considered its business with BGI as 'sensitive' in the least," wrote Ye Yin, the chief operating officer of BGI, in a separate November letter to Complete Genomics.

GenomeWeb Daily News also has more on this here.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.